anti-SARS-CoV-2 monoclonal antibody AZD3152
Term · Oncology and biomedicine · MLC-T-ONC-011081
A long-acting neutralizing human monoclonal antibody derived from B cells of convalescent patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and directed against SARS-CoV-2, that can potentially be used for passive immunization against Coronavirus disease 2019 (COVID-19). Upon administration, anti-SARS-CoV-2 monoclonal antibody AZD3152 neutralizes SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2.
| Identifier | MLC-T-ONC-011081 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011081",
"term": "anti-SARS-CoV-2 monoclonal antibody AZD3152",
"field": "Oncology and biomedicine",
"definition": "A long-acting neutralizing human monoclonal antibody derived from B cells of convalescent patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and directed against SARS-CoV-2, that can potentially be used for passive immunization against Coronavirus disease 2019 (COVID-19). Upon administration, anti-SARS-CoV-2 monoclonal antibody AZD3152 neutralizes SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-sars-cov-2-monoclonal-antibody-azd3152/"
}
Record 2,215 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.